BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6992218)

  • 1. Lymphocytotoxic antibodies.
    DeHoratius RJ
    Prog Clin Immunol; 1980; 4():151-54. PubMed ID: 6992218
    [No Abstract]   [Full Text] [Related]  

  • 2. New conceptions of autoimmunity and of systemic lupus erythematosus.
    Bach JF; Bach MA; Tron F
    Adv Nephrol Necker Hosp; 1976; 6():5-35. PubMed ID: 139083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphocytotoxic antibodies in autoimmune diseases].
    Klingelhöfer HL; Malchow H; Havemann K; Börngen U
    Verh Dtsch Ges Inn Med; 1972; 78():884-7. PubMed ID: 4665773
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-surface modifications of normal human peripheral lymphocytes induced by lymphocytotoxic sera of patients with systemic lupus erythematosus and Hodgkin's disease, studied by scanning electron microscopy.
    Del Giacco GS; Riva A; Loy M; Batzella MG; Cengiarotti L; Leone AL; Locci F; Murru V
    Haematologica; 1979 Apr; 64(2):148-58. PubMed ID: 112006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphocytotoxic antibodies in systemic lupus erythematosus: characteristics and relation to the clinicobiological activity of the disease].
    Font J; Martorell J; Cardellach F; Ingelmo M; Sentís J; Vives J; Balcells A
    Med Clin (Barc); 1986 Jun; 87(3):96-100. PubMed ID: 3736231
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases.
    Bach MA; Bach JF
    Clin Exp Immunol; 1981 Sep; 45(3):449-56. PubMed ID: 6461443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity and suppressor T lymphocytes.
    Miller KB; Schwartz RS
    Adv Intern Med; 1982; 27():281-313. PubMed ID: 7041545
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulins on the surface of lymphocytes in autoimmune disease. II. Lymphocytotoxins on the surface of lymphocytes.
    Gergely P; Szegedi G; Stenszky E; Fekete B; Szabó G; Petrányi G
    Acta Med Acad Sci Hung; 1974; 31(1-2):115-8. PubMed ID: 4549467
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytotoxic antibodies.
    DeHoratius RJ
    In Vivo; 1988; 2(1):67-71. PubMed ID: 2979819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protooncogenes and autoimmunity.
    Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A
    Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance.
    Bresnihan B; Grigor RR; Hughes GR
    J Clin Pathol Suppl (R Coll Pathol); 1979; 13():112-5. PubMed ID: 293333
    [No Abstract]   [Full Text] [Related]  

  • 15. [The lymphocytotoxins].
    Verroust P
    Presse Med (1893); 1971 Jul; 79(33):1485. PubMed ID: 5565230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies against autologous lymphocytes in lupus erythematosus].
    Michlmayr G; Asamer H; Huber C; Huber H
    Klin Wochenschr; 1972 May; 50(9):484-6. PubMed ID: 5043473
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of polymorphonuclear leukocyte (PMNL) factors on T suppressor cell function in in vitro studies in healthy persons and some autoimmune disorders.
    Czernicki J; Tchórzewski H; Lewicki R; Orzel H
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):355-60. PubMed ID: 6457583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T cell immunity in autoimmune disease].
    Fujio K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():56-60. PubMed ID: 15861635
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives.
    DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E
    Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement].
    Graef IT; Henze T; Reiber H
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):587-91. PubMed ID: 7856266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.